Global Geographic Atrophy Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) that causes a continuous progressive degeneration of the macula. The condition is characterized by widespread atrophy of the outer retinal tissue, retinal pigment epithelium, and choriocapillaris. It typically starts in the perifoveal region and develops to the fovea over time and causing central scotomas and permanent vision loss. Various drugs and treatments are under evaluation.
LPI (LP Information)' newest research report, the “Geographic Atrophy Industry Forecast” looks at past sales and reviews total world Geographic Atrophy sales in 2022, providing a comprehensive analysis by region and market sector of projected Geographic Atrophy sales for 2023 through 2029. With Geographic Atrophy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Geographic Atrophy industry.
This Insight Report provides a comprehensive analysis of the global Geographic Atrophy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Geographic Atrophy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Geographic Atrophy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Geographic Atrophy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Geographic Atrophy.
The global Geographic Atrophy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Geographic Atrophy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Geographic Atrophy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Geographic Atrophy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Geographic Atrophy players cover Apellis Pharmaceuticals, Iveric Bio, Alkeus Pharmaceuticals, Hemera Biosciences, Allegro Ophthalmics, Stealth BioTherapeutics, Gyroscope Therapeutics, Regenerative Patch Technologies and Roche, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Geographic Atrophy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) that causes a continuous progressive degeneration of the macula. The condition is characterized by widespread atrophy of the outer retinal tissue, retinal pigment epithelium, and choriocapillaris. It typically starts in the perifoveal region and develops to the fovea over time and causing central scotomas and permanent vision loss. Various drugs and treatments are under evaluation.
LPI (LP Information)' newest research report, the “Geographic Atrophy Industry Forecast” looks at past sales and reviews total world Geographic Atrophy sales in 2022, providing a comprehensive analysis by region and market sector of projected Geographic Atrophy sales for 2023 through 2029. With Geographic Atrophy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Geographic Atrophy industry.
This Insight Report provides a comprehensive analysis of the global Geographic Atrophy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Geographic Atrophy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Geographic Atrophy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Geographic Atrophy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Geographic Atrophy.
The global Geographic Atrophy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Geographic Atrophy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Geographic Atrophy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Geographic Atrophy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Geographic Atrophy players cover Apellis Pharmaceuticals, Iveric Bio, Alkeus Pharmaceuticals, Hemera Biosciences, Allegro Ophthalmics, Stealth BioTherapeutics, Gyroscope Therapeutics, Regenerative Patch Technologies and Roche, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Geographic Atrophy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Above 60 Years
- Above 75 Years
- Late-stage (Phase III)
- Phase II
- Phase I
- Pre-clinical stage
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Apellis Pharmaceuticals
- Iveric Bio
- Alkeus Pharmaceuticals
- Hemera Biosciences
- Allegro Ophthalmics
- Stealth BioTherapeutics
- Gyroscope Therapeutics
- Regenerative Patch Technologies
- Roche
- Gensight Biologics
- NGM Biopharmaceuticals
- AstraZeneca
- Lineage Cell Therapeutics
- Allergan
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Geographic Atrophy Market Size 2018-2029
2.1.2 Geographic Atrophy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Geographic Atrophy Segment by Type
2.2.1 Above 60 Years
2.2.2 Above 75 Years
2.3 Geographic Atrophy Market Size by Type
2.3.1 Geographic Atrophy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Geographic Atrophy Market Size Market Share by Type (2018-2023)
2.4 Geographic Atrophy Segment by Application
2.4.1 Late-stage (Phase III)
2.4.2 Phase II
2.4.3 Phase I
2.4.4 Pre-clinical stage
2.5 Geographic Atrophy Market Size by Application
2.5.1 Geographic Atrophy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Geographic Atrophy Market Size Market Share by Application (2018-2023)
3 GEOGRAPHIC ATROPHY MARKET SIZE BY PLAYER
3.1 Geographic Atrophy Market Size Market Share by Players
3.1.1 Global Geographic Atrophy Revenue by Players (2018-2023)
3.1.2 Global Geographic Atrophy Revenue Market Share by Players (2018-2023)
3.2 Global Geographic Atrophy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GEOGRAPHIC ATROPHY BY REGIONS
4.1 Geographic Atrophy Market Size by Regions (2018-2023)
4.2 Americas Geographic Atrophy Market Size Growth (2018-2023)
4.3 APAC Geographic Atrophy Market Size Growth (2018-2023)
4.4 Europe Geographic Atrophy Market Size Growth (2018-2023)
4.5 Middle East & Africa Geographic Atrophy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Geographic Atrophy Market Size by Country (2018-2023)
5.2 Americas Geographic Atrophy Market Size by Type (2018-2023)
5.3 Americas Geographic Atrophy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Geographic Atrophy Market Size by Region (2018-2023)
6.2 APAC Geographic Atrophy Market Size by Type (2018-2023)
6.3 APAC Geographic Atrophy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Geographic Atrophy by Country (2018-2023)
7.2 Europe Geographic Atrophy Market Size by Type (2018-2023)
7.3 Europe Geographic Atrophy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Geographic Atrophy by Region (2018-2023)
8.2 Middle East & Africa Geographic Atrophy Market Size by Type (2018-2023)
8.3 Middle East & Africa Geographic Atrophy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GEOGRAPHIC ATROPHY MARKET FORECAST
10.1 Global Geographic Atrophy Forecast by Regions (2024-2029)
10.1.1 Global Geographic Atrophy Forecast by Regions (2024-2029)
10.1.2 Americas Geographic Atrophy Forecast
10.1.3 APAC Geographic Atrophy Forecast
10.1.4 Europe Geographic Atrophy Forecast
10.1.5 Middle East & Africa Geographic Atrophy Forecast
10.2 Americas Geographic Atrophy Forecast by Country (2024-2029)
10.2.1 United States Geographic Atrophy Market Forecast
10.2.2 Canada Geographic Atrophy Market Forecast
10.2.3 Mexico Geographic Atrophy Market Forecast
10.2.4 Brazil Geographic Atrophy Market Forecast
10.3 APAC Geographic Atrophy Forecast by Region (2024-2029)
10.3.1 China Geographic Atrophy Market Forecast
10.3.2 Japan Geographic Atrophy Market Forecast
10.3.3 Korea Geographic Atrophy Market Forecast
10.3.4 Southeast Asia Geographic Atrophy Market Forecast
10.3.5 India Geographic Atrophy Market Forecast
10.3.6 Australia Geographic Atrophy Market Forecast
10.4 Europe Geographic Atrophy Forecast by Country (2024-2029)
10.4.1 Germany Geographic Atrophy Market Forecast
10.4.2 France Geographic Atrophy Market Forecast
10.4.3 UK Geographic Atrophy Market Forecast
10.4.4 Italy Geographic Atrophy Market Forecast
10.4.5 Russia Geographic Atrophy Market Forecast
10.5 Middle East & Africa Geographic Atrophy Forecast by Region (2024-2029)
10.5.1 Egypt Geographic Atrophy Market Forecast
10.5.2 South Africa Geographic Atrophy Market Forecast
10.5.3 Israel Geographic Atrophy Market Forecast
10.5.4 Turkey Geographic Atrophy Market Forecast
10.5.5 GCC Countries Geographic Atrophy Market Forecast
10.6 Global Geographic Atrophy Forecast by Type (2024-2029)
10.7 Global Geographic Atrophy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Apellis Pharmaceuticals
11.1.1 Apellis Pharmaceuticals Company Information
11.1.2 Apellis Pharmaceuticals Geographic Atrophy Product Offered
11.1.3 Apellis Pharmaceuticals Geographic Atrophy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Apellis Pharmaceuticals Main Business Overview
11.1.5 Apellis Pharmaceuticals Latest Developments
11.2 Iveric Bio
11.2.1 Iveric Bio Company Information
11.2.2 Iveric Bio Geographic Atrophy Product Offered
11.2.3 Iveric Bio Geographic Atrophy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Iveric Bio Main Business Overview
11.2.5 Iveric Bio Latest Developments
11.3 Alkeus Pharmaceuticals
11.3.1 Alkeus Pharmaceuticals Company Information
11.3.2 Alkeus Pharmaceuticals Geographic Atrophy Product Offered
11.3.3 Alkeus Pharmaceuticals Geographic Atrophy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Alkeus Pharmaceuticals Main Business Overview
11.3.5 Alkeus Pharmaceuticals Latest Developments
11.4 Hemera Biosciences
11.4.1 Hemera Biosciences Company Information
11.4.2 Hemera Biosciences Geographic Atrophy Product Offered
11.4.3 Hemera Biosciences Geographic Atrophy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Hemera Biosciences Main Business Overview
11.4.5 Hemera Biosciences Latest Developments
11.5 Allegro Ophthalmics
11.5.1 Allegro Ophthalmics Company Information
11.5.2 Allegro Ophthalmics Geographic Atrophy Product Offered
11.5.3 Allegro Ophthalmics Geographic Atrophy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Allegro Ophthalmics Main Business Overview
11.5.5 Allegro Ophthalmics Latest Developments
11.6 Stealth BioTherapeutics
11.6.1 Stealth BioTherapeutics Company Information
11.6.2 Stealth BioTherapeutics Geographic Atrophy Product Offered
11.6.3 Stealth BioTherapeutics Geographic Atrophy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Stealth BioTherapeutics Main Business Overview
11.6.5 Stealth BioTherapeutics Latest Developments
11.7 Gyroscope Therapeutics
11.7.1 Gyroscope Therapeutics Company Information
11.7.2 Gyroscope Therapeutics Geographic Atrophy Product Offered
11.7.3 Gyroscope Therapeutics Geographic Atrophy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Gyroscope Therapeutics Main Business Overview
11.7.5 Gyroscope Therapeutics Latest Developments
11.8 Regenerative Patch Technologies
11.8.1 Regenerative Patch Technologies Company Information
11.8.2 Regenerative Patch Technologies Geographic Atrophy Product Offered
11.8.3 Regenerative Patch Technologies Geographic Atrophy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Regenerative Patch Technologies Main Business Overview
11.8.5 Regenerative Patch Technologies Latest Developments
11.9 Roche
11.9.1 Roche Company Information
11.9.2 Roche Geographic Atrophy Product Offered
11.9.3 Roche Geographic Atrophy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Roche Main Business Overview
11.9.5 Roche Latest Developments
11.10 Gensight Biologics
11.10.1 Gensight Biologics Company Information
11.10.2 Gensight Biologics Geographic Atrophy Product Offered
11.10.3 Gensight Biologics Geographic Atrophy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Gensight Biologics Main Business Overview
11.10.5 Gensight Biologics Latest Developments
11.11 NGM Biopharmaceuticals
11.11.1 NGM Biopharmaceuticals Company Information
11.11.2 NGM Biopharmaceuticals Geographic Atrophy Product Offered
11.11.3 NGM Biopharmaceuticals Geographic Atrophy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 NGM Biopharmaceuticals Main Business Overview
11.11.5 NGM Biopharmaceuticals Latest Developments
11.12 AstraZeneca
11.12.1 AstraZeneca Company Information
11.12.2 AstraZeneca Geographic Atrophy Product Offered
11.12.3 AstraZeneca Geographic Atrophy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 AstraZeneca Main Business Overview
11.12.5 AstraZeneca Latest Developments
11.13 Lineage Cell Therapeutics
11.13.1 Lineage Cell Therapeutics Company Information
11.13.2 Lineage Cell Therapeutics Geographic Atrophy Product Offered
11.13.3 Lineage Cell Therapeutics Geographic Atrophy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Lineage Cell Therapeutics Main Business Overview
11.13.5 Lineage Cell Therapeutics Latest Developments
11.14 Allergan
11.14.1 Allergan Company Information
11.14.2 Allergan Geographic Atrophy Product Offered
11.14.3 Allergan Geographic Atrophy Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Allergan Main Business Overview
11.14.5 Allergan Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Geographic Atrophy Market Size 2018-2029
2.1.2 Geographic Atrophy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Geographic Atrophy Segment by Type
2.2.1 Above 60 Years
2.2.2 Above 75 Years
2.3 Geographic Atrophy Market Size by Type
2.3.1 Geographic Atrophy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Geographic Atrophy Market Size Market Share by Type (2018-2023)
2.4 Geographic Atrophy Segment by Application
2.4.1 Late-stage (Phase III)
2.4.2 Phase II
2.4.3 Phase I
2.4.4 Pre-clinical stage
2.5 Geographic Atrophy Market Size by Application
2.5.1 Geographic Atrophy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Geographic Atrophy Market Size Market Share by Application (2018-2023)
3 GEOGRAPHIC ATROPHY MARKET SIZE BY PLAYER
3.1 Geographic Atrophy Market Size Market Share by Players
3.1.1 Global Geographic Atrophy Revenue by Players (2018-2023)
3.1.2 Global Geographic Atrophy Revenue Market Share by Players (2018-2023)
3.2 Global Geographic Atrophy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GEOGRAPHIC ATROPHY BY REGIONS
4.1 Geographic Atrophy Market Size by Regions (2018-2023)
4.2 Americas Geographic Atrophy Market Size Growth (2018-2023)
4.3 APAC Geographic Atrophy Market Size Growth (2018-2023)
4.4 Europe Geographic Atrophy Market Size Growth (2018-2023)
4.5 Middle East & Africa Geographic Atrophy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Geographic Atrophy Market Size by Country (2018-2023)
5.2 Americas Geographic Atrophy Market Size by Type (2018-2023)
5.3 Americas Geographic Atrophy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Geographic Atrophy Market Size by Region (2018-2023)
6.2 APAC Geographic Atrophy Market Size by Type (2018-2023)
6.3 APAC Geographic Atrophy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Geographic Atrophy by Country (2018-2023)
7.2 Europe Geographic Atrophy Market Size by Type (2018-2023)
7.3 Europe Geographic Atrophy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Geographic Atrophy by Region (2018-2023)
8.2 Middle East & Africa Geographic Atrophy Market Size by Type (2018-2023)
8.3 Middle East & Africa Geographic Atrophy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GEOGRAPHIC ATROPHY MARKET FORECAST
10.1 Global Geographic Atrophy Forecast by Regions (2024-2029)
10.1.1 Global Geographic Atrophy Forecast by Regions (2024-2029)
10.1.2 Americas Geographic Atrophy Forecast
10.1.3 APAC Geographic Atrophy Forecast
10.1.4 Europe Geographic Atrophy Forecast
10.1.5 Middle East & Africa Geographic Atrophy Forecast
10.2 Americas Geographic Atrophy Forecast by Country (2024-2029)
10.2.1 United States Geographic Atrophy Market Forecast
10.2.2 Canada Geographic Atrophy Market Forecast
10.2.3 Mexico Geographic Atrophy Market Forecast
10.2.4 Brazil Geographic Atrophy Market Forecast
10.3 APAC Geographic Atrophy Forecast by Region (2024-2029)
10.3.1 China Geographic Atrophy Market Forecast
10.3.2 Japan Geographic Atrophy Market Forecast
10.3.3 Korea Geographic Atrophy Market Forecast
10.3.4 Southeast Asia Geographic Atrophy Market Forecast
10.3.5 India Geographic Atrophy Market Forecast
10.3.6 Australia Geographic Atrophy Market Forecast
10.4 Europe Geographic Atrophy Forecast by Country (2024-2029)
10.4.1 Germany Geographic Atrophy Market Forecast
10.4.2 France Geographic Atrophy Market Forecast
10.4.3 UK Geographic Atrophy Market Forecast
10.4.4 Italy Geographic Atrophy Market Forecast
10.4.5 Russia Geographic Atrophy Market Forecast
10.5 Middle East & Africa Geographic Atrophy Forecast by Region (2024-2029)
10.5.1 Egypt Geographic Atrophy Market Forecast
10.5.2 South Africa Geographic Atrophy Market Forecast
10.5.3 Israel Geographic Atrophy Market Forecast
10.5.4 Turkey Geographic Atrophy Market Forecast
10.5.5 GCC Countries Geographic Atrophy Market Forecast
10.6 Global Geographic Atrophy Forecast by Type (2024-2029)
10.7 Global Geographic Atrophy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Apellis Pharmaceuticals
11.1.1 Apellis Pharmaceuticals Company Information
11.1.2 Apellis Pharmaceuticals Geographic Atrophy Product Offered
11.1.3 Apellis Pharmaceuticals Geographic Atrophy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Apellis Pharmaceuticals Main Business Overview
11.1.5 Apellis Pharmaceuticals Latest Developments
11.2 Iveric Bio
11.2.1 Iveric Bio Company Information
11.2.2 Iveric Bio Geographic Atrophy Product Offered
11.2.3 Iveric Bio Geographic Atrophy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Iveric Bio Main Business Overview
11.2.5 Iveric Bio Latest Developments
11.3 Alkeus Pharmaceuticals
11.3.1 Alkeus Pharmaceuticals Company Information
11.3.2 Alkeus Pharmaceuticals Geographic Atrophy Product Offered
11.3.3 Alkeus Pharmaceuticals Geographic Atrophy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Alkeus Pharmaceuticals Main Business Overview
11.3.5 Alkeus Pharmaceuticals Latest Developments
11.4 Hemera Biosciences
11.4.1 Hemera Biosciences Company Information
11.4.2 Hemera Biosciences Geographic Atrophy Product Offered
11.4.3 Hemera Biosciences Geographic Atrophy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Hemera Biosciences Main Business Overview
11.4.5 Hemera Biosciences Latest Developments
11.5 Allegro Ophthalmics
11.5.1 Allegro Ophthalmics Company Information
11.5.2 Allegro Ophthalmics Geographic Atrophy Product Offered
11.5.3 Allegro Ophthalmics Geographic Atrophy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Allegro Ophthalmics Main Business Overview
11.5.5 Allegro Ophthalmics Latest Developments
11.6 Stealth BioTherapeutics
11.6.1 Stealth BioTherapeutics Company Information
11.6.2 Stealth BioTherapeutics Geographic Atrophy Product Offered
11.6.3 Stealth BioTherapeutics Geographic Atrophy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Stealth BioTherapeutics Main Business Overview
11.6.5 Stealth BioTherapeutics Latest Developments
11.7 Gyroscope Therapeutics
11.7.1 Gyroscope Therapeutics Company Information
11.7.2 Gyroscope Therapeutics Geographic Atrophy Product Offered
11.7.3 Gyroscope Therapeutics Geographic Atrophy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Gyroscope Therapeutics Main Business Overview
11.7.5 Gyroscope Therapeutics Latest Developments
11.8 Regenerative Patch Technologies
11.8.1 Regenerative Patch Technologies Company Information
11.8.2 Regenerative Patch Technologies Geographic Atrophy Product Offered
11.8.3 Regenerative Patch Technologies Geographic Atrophy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Regenerative Patch Technologies Main Business Overview
11.8.5 Regenerative Patch Technologies Latest Developments
11.9 Roche
11.9.1 Roche Company Information
11.9.2 Roche Geographic Atrophy Product Offered
11.9.3 Roche Geographic Atrophy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Roche Main Business Overview
11.9.5 Roche Latest Developments
11.10 Gensight Biologics
11.10.1 Gensight Biologics Company Information
11.10.2 Gensight Biologics Geographic Atrophy Product Offered
11.10.3 Gensight Biologics Geographic Atrophy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Gensight Biologics Main Business Overview
11.10.5 Gensight Biologics Latest Developments
11.11 NGM Biopharmaceuticals
11.11.1 NGM Biopharmaceuticals Company Information
11.11.2 NGM Biopharmaceuticals Geographic Atrophy Product Offered
11.11.3 NGM Biopharmaceuticals Geographic Atrophy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 NGM Biopharmaceuticals Main Business Overview
11.11.5 NGM Biopharmaceuticals Latest Developments
11.12 AstraZeneca
11.12.1 AstraZeneca Company Information
11.12.2 AstraZeneca Geographic Atrophy Product Offered
11.12.3 AstraZeneca Geographic Atrophy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 AstraZeneca Main Business Overview
11.12.5 AstraZeneca Latest Developments
11.13 Lineage Cell Therapeutics
11.13.1 Lineage Cell Therapeutics Company Information
11.13.2 Lineage Cell Therapeutics Geographic Atrophy Product Offered
11.13.3 Lineage Cell Therapeutics Geographic Atrophy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Lineage Cell Therapeutics Main Business Overview
11.13.5 Lineage Cell Therapeutics Latest Developments
11.14 Allergan
11.14.1 Allergan Company Information
11.14.2 Allergan Geographic Atrophy Product Offered
11.14.3 Allergan Geographic Atrophy Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Allergan Main Business Overview
11.14.5 Allergan Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Geographic Atrophy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Above 60 Years
Table 3. Major Players of Above 75 Years
Table 4. Geographic Atrophy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Geographic Atrophy Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Geographic Atrophy Market Size Market Share by Type (2018-2023)
Table 7. Geographic Atrophy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Geographic Atrophy Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Geographic Atrophy Market Size Market Share by Application (2018-2023)
Table 10. Global Geographic Atrophy Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Geographic Atrophy Revenue Market Share by Player (2018-2023)
Table 12. Geographic Atrophy Key Players Head office and Products Offered
Table 13. Geographic Atrophy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Geographic Atrophy Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Geographic Atrophy Market Size Market Share by Regions (2018-2023)
Table 18. Global Geographic Atrophy Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Geographic Atrophy Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Geographic Atrophy Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Geographic Atrophy Market Size Market Share by Country (2018-2023)
Table 22. Americas Geographic Atrophy Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Geographic Atrophy Market Size Market Share by Type (2018-2023)
Table 24. Americas Geographic Atrophy Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Geographic Atrophy Market Size Market Share by Application (2018-2023)
Table 26. APAC Geographic Atrophy Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Geographic Atrophy Market Size Market Share by Region (2018-2023)
Table 28. APAC Geographic Atrophy Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Geographic Atrophy Market Size Market Share by Type (2018-2023)
Table 30. APAC Geographic Atrophy Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Geographic Atrophy Market Size Market Share by Application (2018-2023)
Table 32. Europe Geographic Atrophy Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Geographic Atrophy Market Size Market Share by Country (2018-2023)
Table 34. Europe Geographic Atrophy Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Geographic Atrophy Market Size Market Share by Type (2018-2023)
Table 36. Europe Geographic Atrophy Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Geographic Atrophy Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Geographic Atrophy Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Geographic Atrophy Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Geographic Atrophy Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Geographic Atrophy Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Geographic Atrophy Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Geographic Atrophy Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Geographic Atrophy
Table 45. Key Market Challenges & Risks of Geographic Atrophy
Table 46. Key Industry Trends of Geographic Atrophy
Table 47. Global Geographic Atrophy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Geographic Atrophy Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Geographic Atrophy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Geographic Atrophy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Apellis Pharmaceuticals Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 52. Apellis Pharmaceuticals Geographic Atrophy Product Offered
Table 53. Apellis Pharmaceuticals Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Apellis Pharmaceuticals Main Business
Table 55. Apellis Pharmaceuticals Latest Developments
Table 56. Iveric Bio Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 57. Iveric Bio Geographic Atrophy Product Offered
Table 58. Iveric Bio Main Business
Table 59. Iveric Bio Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Iveric Bio Latest Developments
Table 61. Alkeus Pharmaceuticals Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 62. Alkeus Pharmaceuticals Geographic Atrophy Product Offered
Table 63. Alkeus Pharmaceuticals Main Business
Table 64. Alkeus Pharmaceuticals Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Alkeus Pharmaceuticals Latest Developments
Table 66. Hemera Biosciences Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 67. Hemera Biosciences Geographic Atrophy Product Offered
Table 68. Hemera Biosciences Main Business
Table 69. Hemera Biosciences Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Hemera Biosciences Latest Developments
Table 71. Allegro Ophthalmics Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 72. Allegro Ophthalmics Geographic Atrophy Product Offered
Table 73. Allegro Ophthalmics Main Business
Table 74. Allegro Ophthalmics Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Allegro Ophthalmics Latest Developments
Table 76. Stealth BioTherapeutics Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 77. Stealth BioTherapeutics Geographic Atrophy Product Offered
Table 78. Stealth BioTherapeutics Main Business
Table 79. Stealth BioTherapeutics Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Stealth BioTherapeutics Latest Developments
Table 81. Gyroscope Therapeutics Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 82. Gyroscope Therapeutics Geographic Atrophy Product Offered
Table 83. Gyroscope Therapeutics Main Business
Table 84. Gyroscope Therapeutics Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Gyroscope Therapeutics Latest Developments
Table 86. Regenerative Patch Technologies Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 87. Regenerative Patch Technologies Geographic Atrophy Product Offered
Table 88. Regenerative Patch Technologies Main Business
Table 89. Regenerative Patch Technologies Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Regenerative Patch Technologies Latest Developments
Table 91. Roche Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 92. Roche Geographic Atrophy Product Offered
Table 93. Roche Main Business
Table 94. Roche Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Roche Latest Developments
Table 96. Gensight Biologics Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 97. Gensight Biologics Geographic Atrophy Product Offered
Table 98. Gensight Biologics Main Business
Table 99. Gensight Biologics Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Gensight Biologics Latest Developments
Table 101. NGM Biopharmaceuticals Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 102. NGM Biopharmaceuticals Geographic Atrophy Product Offered
Table 103. NGM Biopharmaceuticals Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. NGM Biopharmaceuticals Main Business
Table 105. NGM Biopharmaceuticals Latest Developments
Table 106. AstraZeneca Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 107. AstraZeneca Geographic Atrophy Product Offered
Table 108. AstraZeneca Main Business
Table 109. AstraZeneca Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. AstraZeneca Latest Developments
Table 111. Lineage Cell Therapeutics Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 112. Lineage Cell Therapeutics Geographic Atrophy Product Offered
Table 113. Lineage Cell Therapeutics Main Business
Table 114. Lineage Cell Therapeutics Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Lineage Cell Therapeutics Latest Developments
Table 116. Allergan Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 117. Allergan Geographic Atrophy Product Offered
Table 118. Allergan Main Business
Table 119. Allergan Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Allergan Latest Developments
Table 1. Geographic Atrophy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Above 60 Years
Table 3. Major Players of Above 75 Years
Table 4. Geographic Atrophy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Geographic Atrophy Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Geographic Atrophy Market Size Market Share by Type (2018-2023)
Table 7. Geographic Atrophy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Geographic Atrophy Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Geographic Atrophy Market Size Market Share by Application (2018-2023)
Table 10. Global Geographic Atrophy Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Geographic Atrophy Revenue Market Share by Player (2018-2023)
Table 12. Geographic Atrophy Key Players Head office and Products Offered
Table 13. Geographic Atrophy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Geographic Atrophy Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Geographic Atrophy Market Size Market Share by Regions (2018-2023)
Table 18. Global Geographic Atrophy Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Geographic Atrophy Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Geographic Atrophy Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Geographic Atrophy Market Size Market Share by Country (2018-2023)
Table 22. Americas Geographic Atrophy Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Geographic Atrophy Market Size Market Share by Type (2018-2023)
Table 24. Americas Geographic Atrophy Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Geographic Atrophy Market Size Market Share by Application (2018-2023)
Table 26. APAC Geographic Atrophy Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Geographic Atrophy Market Size Market Share by Region (2018-2023)
Table 28. APAC Geographic Atrophy Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Geographic Atrophy Market Size Market Share by Type (2018-2023)
Table 30. APAC Geographic Atrophy Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Geographic Atrophy Market Size Market Share by Application (2018-2023)
Table 32. Europe Geographic Atrophy Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Geographic Atrophy Market Size Market Share by Country (2018-2023)
Table 34. Europe Geographic Atrophy Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Geographic Atrophy Market Size Market Share by Type (2018-2023)
Table 36. Europe Geographic Atrophy Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Geographic Atrophy Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Geographic Atrophy Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Geographic Atrophy Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Geographic Atrophy Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Geographic Atrophy Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Geographic Atrophy Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Geographic Atrophy Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Geographic Atrophy
Table 45. Key Market Challenges & Risks of Geographic Atrophy
Table 46. Key Industry Trends of Geographic Atrophy
Table 47. Global Geographic Atrophy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Geographic Atrophy Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Geographic Atrophy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Geographic Atrophy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Apellis Pharmaceuticals Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 52. Apellis Pharmaceuticals Geographic Atrophy Product Offered
Table 53. Apellis Pharmaceuticals Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Apellis Pharmaceuticals Main Business
Table 55. Apellis Pharmaceuticals Latest Developments
Table 56. Iveric Bio Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 57. Iveric Bio Geographic Atrophy Product Offered
Table 58. Iveric Bio Main Business
Table 59. Iveric Bio Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Iveric Bio Latest Developments
Table 61. Alkeus Pharmaceuticals Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 62. Alkeus Pharmaceuticals Geographic Atrophy Product Offered
Table 63. Alkeus Pharmaceuticals Main Business
Table 64. Alkeus Pharmaceuticals Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Alkeus Pharmaceuticals Latest Developments
Table 66. Hemera Biosciences Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 67. Hemera Biosciences Geographic Atrophy Product Offered
Table 68. Hemera Biosciences Main Business
Table 69. Hemera Biosciences Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Hemera Biosciences Latest Developments
Table 71. Allegro Ophthalmics Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 72. Allegro Ophthalmics Geographic Atrophy Product Offered
Table 73. Allegro Ophthalmics Main Business
Table 74. Allegro Ophthalmics Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Allegro Ophthalmics Latest Developments
Table 76. Stealth BioTherapeutics Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 77. Stealth BioTherapeutics Geographic Atrophy Product Offered
Table 78. Stealth BioTherapeutics Main Business
Table 79. Stealth BioTherapeutics Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Stealth BioTherapeutics Latest Developments
Table 81. Gyroscope Therapeutics Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 82. Gyroscope Therapeutics Geographic Atrophy Product Offered
Table 83. Gyroscope Therapeutics Main Business
Table 84. Gyroscope Therapeutics Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Gyroscope Therapeutics Latest Developments
Table 86. Regenerative Patch Technologies Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 87. Regenerative Patch Technologies Geographic Atrophy Product Offered
Table 88. Regenerative Patch Technologies Main Business
Table 89. Regenerative Patch Technologies Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Regenerative Patch Technologies Latest Developments
Table 91. Roche Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 92. Roche Geographic Atrophy Product Offered
Table 93. Roche Main Business
Table 94. Roche Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Roche Latest Developments
Table 96. Gensight Biologics Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 97. Gensight Biologics Geographic Atrophy Product Offered
Table 98. Gensight Biologics Main Business
Table 99. Gensight Biologics Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Gensight Biologics Latest Developments
Table 101. NGM Biopharmaceuticals Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 102. NGM Biopharmaceuticals Geographic Atrophy Product Offered
Table 103. NGM Biopharmaceuticals Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. NGM Biopharmaceuticals Main Business
Table 105. NGM Biopharmaceuticals Latest Developments
Table 106. AstraZeneca Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 107. AstraZeneca Geographic Atrophy Product Offered
Table 108. AstraZeneca Main Business
Table 109. AstraZeneca Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. AstraZeneca Latest Developments
Table 111. Lineage Cell Therapeutics Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 112. Lineage Cell Therapeutics Geographic Atrophy Product Offered
Table 113. Lineage Cell Therapeutics Main Business
Table 114. Lineage Cell Therapeutics Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Lineage Cell Therapeutics Latest Developments
Table 116. Allergan Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 117. Allergan Geographic Atrophy Product Offered
Table 118. Allergan Main Business
Table 119. Allergan Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Allergan Latest Developments
LIST OF FIGURES
Figure 1. Geographic Atrophy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Geographic Atrophy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Geographic Atrophy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Geographic Atrophy Sales Market Share by Country/Region (2022)
Figure 8. Geographic Atrophy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Geographic Atrophy Market Size Market Share by Type in 2022
Figure 10. Geographic Atrophy in Late-stage (Phase III)
Figure 11. Global Geographic Atrophy Market: Late-stage (Phase III) (2018-2023) & ($ Millions)
Figure 12. Geographic Atrophy in Phase II
Figure 13. Global Geographic Atrophy Market: Phase II (2018-2023) & ($ Millions)
Figure 14. Geographic Atrophy in Phase I
Figure 15. Global Geographic Atrophy Market: Phase I (2018-2023) & ($ Millions)
Figure 16. Geographic Atrophy in Pre-clinical stage
Figure 17. Global Geographic Atrophy Market: Pre-clinical stage (2018-2023) & ($ Millions)
Figure 18. Global Geographic Atrophy Market Size Market Share by Application in 2022
Figure 19. Global Geographic Atrophy Revenue Market Share by Player in 2022
Figure 20. Global Geographic Atrophy Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Geographic Atrophy Market Size 2018-2023 ($ Millions)
Figure 22. APAC Geographic Atrophy Market Size 2018-2023 ($ Millions)
Figure 23. Europe Geographic Atrophy Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Geographic Atrophy Market Size 2018-2023 ($ Millions)
Figure 25. Americas Geographic Atrophy Value Market Share by Country in 2022
Figure 26. United States Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Geographic Atrophy Market Size Market Share by Region in 2022
Figure 31. APAC Geographic Atrophy Market Size Market Share by Type in 2022
Figure 32. APAC Geographic Atrophy Market Size Market Share by Application in 2022
Figure 33. China Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Geographic Atrophy Market Size Market Share by Country in 2022
Figure 40. Europe Geographic Atrophy Market Size Market Share by Type (2018-2023)
Figure 41. Europe Geographic Atrophy Market Size Market Share by Application (2018-2023)
Figure 42. Germany Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Geographic Atrophy Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Geographic Atrophy Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Geographic Atrophy Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 56. APAC Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 57. Europe Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 59. United States Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 60. Canada Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 63. China Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 64. Japan Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 65. Korea Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 67. India Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 68. Australia Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 69. Germany Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 70. France Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 71. UK Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 72. Italy Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 73. Russia Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 74. Spain Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 77. Israel Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 80. Global Geographic Atrophy Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Geographic Atrophy Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Geographic Atrophy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Geographic Atrophy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Geographic Atrophy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Geographic Atrophy Sales Market Share by Country/Region (2022)
Figure 8. Geographic Atrophy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Geographic Atrophy Market Size Market Share by Type in 2022
Figure 10. Geographic Atrophy in Late-stage (Phase III)
Figure 11. Global Geographic Atrophy Market: Late-stage (Phase III) (2018-2023) & ($ Millions)
Figure 12. Geographic Atrophy in Phase II
Figure 13. Global Geographic Atrophy Market: Phase II (2018-2023) & ($ Millions)
Figure 14. Geographic Atrophy in Phase I
Figure 15. Global Geographic Atrophy Market: Phase I (2018-2023) & ($ Millions)
Figure 16. Geographic Atrophy in Pre-clinical stage
Figure 17. Global Geographic Atrophy Market: Pre-clinical stage (2018-2023) & ($ Millions)
Figure 18. Global Geographic Atrophy Market Size Market Share by Application in 2022
Figure 19. Global Geographic Atrophy Revenue Market Share by Player in 2022
Figure 20. Global Geographic Atrophy Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Geographic Atrophy Market Size 2018-2023 ($ Millions)
Figure 22. APAC Geographic Atrophy Market Size 2018-2023 ($ Millions)
Figure 23. Europe Geographic Atrophy Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Geographic Atrophy Market Size 2018-2023 ($ Millions)
Figure 25. Americas Geographic Atrophy Value Market Share by Country in 2022
Figure 26. United States Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Geographic Atrophy Market Size Market Share by Region in 2022
Figure 31. APAC Geographic Atrophy Market Size Market Share by Type in 2022
Figure 32. APAC Geographic Atrophy Market Size Market Share by Application in 2022
Figure 33. China Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Geographic Atrophy Market Size Market Share by Country in 2022
Figure 40. Europe Geographic Atrophy Market Size Market Share by Type (2018-2023)
Figure 41. Europe Geographic Atrophy Market Size Market Share by Application (2018-2023)
Figure 42. Germany Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Geographic Atrophy Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Geographic Atrophy Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Geographic Atrophy Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Geographic Atrophy Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 56. APAC Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 57. Europe Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 59. United States Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 60. Canada Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 63. China Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 64. Japan Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 65. Korea Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 67. India Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 68. Australia Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 69. Germany Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 70. France Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 71. UK Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 72. Italy Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 73. Russia Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 74. Spain Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 77. Israel Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Geographic Atrophy Market Size 2024-2029 ($ Millions)
Figure 80. Global Geographic Atrophy Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Geographic Atrophy Market Size Market Share Forecast by Application (2024-2029)
